PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications

Pancreatic cancer is a highly lethal disease with a poor prognosis, and existing therapies offer only limited effectiveness. Mutation gene sequencing has shown several gene associations that may account for its carcinogenesis, revealing a promising research direction. Poly (ADP-ribose) polymerase (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Heng, Wei, Miaoyan, Xu, Jin, Hua, Jie, Liang, Chen, Meng, Qingcai, Zhang, Yiyin, Liu, Jiang, Zhang, Bo, Yu, Xianjun, Shi, Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053129/
https://www.ncbi.nlm.nih.gov/pubmed/32122376
http://dx.doi.org/10.1186/s12943-020-01167-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053129/
https://www.ncbi.nlm.nih.gov/pubmed/32122376
http://dx.doi.org/10.1186/s12943-020-01167-9

Ejemplares similares